Cannabidiol & Glucose Tolerance: Clinical Evidence Review
This review covers cannabidiol glucose tolerance clinical evidence from recent pilot studies. Short-term low-dose CBD supplementation did not improve glucose tolerance in overweight adults. The findings highlight the need for larger trials to clarify…
Research Digest: 20 Recent Studies – March 18, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81 Research Authority…
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
This article reviews cannabinoid clinical trials CBD glucose effects on metabolic health. Short-term low-dose CBD supplementation showed no significant improvements in glucose tolerance or gut microbiome. These findings highlight the need for further…
Cannabidiol & Glucose Tolerance: Clinical Research Review
This article reviews cannabidiol glucose tolerance clinical trial findings in sedentary adults with overweight or obesity. The study found no significant improvements in glucose tolerance or gut microbiome with low-dose CBD. These findings highlight the…
Endocannabinoid System Clinical Research: CBD & Metabolism Analysis
This cannabidiol glucose tolerance clinical research evaluates the impact of low-dose CBD supplementation on metabolic health. The study found no significant improvements in glucose tolerance or gut microbiome composition. These findings highlight the…